Home > preclinical compounds
Published on 09/02/2024
Looking for new therapeutic approaches for AD
Almirall and CRG collaborate to identify molecular pathways and biomarkers specific to atopic dermatitis.
Published on 25/05/2023
New models for non-melanoma skin cancer
Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer
Published on 28/11/2022
Almirall joins IMI project FACILITATE
We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.